Update
$BioCryst Pharmaceuticals(BCRX.US$ Benzinga· 1 min BioCryst Presents New Real-world Evidence Showing Significant Reductions In Healthcare Resource Utilization Among Patients With Hereditary Angioedema Following Initiation Of Orladeyo (Berotralstat
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Jaguar8 : This I like! Good for patients and healthcare institutions
TrytosaveabitOP Jaguar8: Yup yup!